H-1B sponsorship profile: Hikma Pharmaceuticals USA Inc. Across U.S. Department of Labor LCA disclosures, Hikma Pharmaceuticals USA Inc filed 78 Labor Condition Applications covering 78 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 97.4% (76 certified of 78 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Hikma Pharmaceuticals USA Inc’s H-1B petitions range from $52,062 at the low end to $172,307 at the high end, with a petition-weighted average of $109,489. That range reflects the mix of occupations the company sponsors, led by Principal Scientist, Analytical Research (10 petitions at $103,909 avg), followed by Sr. Scientist, Analytical Research and Sr. Scientist, Formulation Development. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Hikma Pharmaceuticals USA Inc is headquartered in Berkeley Heights, NJ under NAICS code 325412, and places H-1B workers across 2 states, most heavily in OH, NJ. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.

Where Hikma Pharmaceuticals USA Inc ranks. By H-1B petition volume, Hikma Pharmaceuticals USA Inc is #2,966 of 119,880 employers nationally and #300 of 5,818 employers headquartered in NJ. Both ranks are computed live from the same underlying petition counts, not a separate estimate.